Eugene L. Stewart

3.1k citations

47 papers · 2.2k indexed · 1 hit paper · h-index 20

Genetics top 2%
Molecular Biology top 10%
Endocrinology, Diabetes and Metabolism top 2%
Organic Chemistry top 5%
Oncology

Co-authors: Thomas B. Stanley Randy K. Bledsoe Kenneth H. Pearce Millard H. Lambert Timothy M. Willson Shawn P. Williams C.J. Apolito Kevin P. Madauss
Topics: Estrogen and related hormone effects (17 papers)HIV/AIDS drug development and treatment (7 papers)HIV Research and Treatment (7 papers)
Cited by: Genetics Endocrinology, Diabetes and Metabolism Toxicology
Journals: Cell Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Eugene L. Stewart

45 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition

2002 652 citations Randy K. Bledsoe, Valerie G. Montana et al. Cell profile →

Peers

Countries citing papers authored by Eugene L. Stewart

Since Specialization

Citations

This map shows the geographic impact of Eugene L. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene L. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene L. Stewart more than expected).

Fields of papers citing papers by Eugene L. Stewart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene L. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene L. Stewart. The network helps show where Eugene L. Stewart may publish in the future.

Co-authorship network of co-authors of Eugene L. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene L. Stewart. A scholar is included among the top collaborators of Eugene L. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene L. Stewart. Eugene L. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate 2024 ·Antiviral Research ·(unknown),Margaret Gartland,Jagadish Beloor,(unknown),Jana Wolf,Eugene L. Stewart,Andrew Clark,Allan R. Tenorio,(unknown)	0
2	Novel Bent Conformation of CD4 Induced by HIV-1 Inhibitor Indirectly Prevents Productive Viral Attachment 2021 ·Journal of Molecular Biology ·(unknown),Shawn P. Williams,David P. Dixon,Paris Ward,(unknown),N.O. Concha,Eugene L. Stewart,Xuan Hong,Charles E. Mazzucco,(unknown),Bo Ding,Christoph H. Fellinger,(unknown)	1
3	Complementary NAD+ replacement strategies fail to functionally protect dystrophin-deficient muscle 2020 ·Skeletal Muscle ·David W. Frederick,(unknown),(unknown),Johanna Vappiani,Andrea Nuzzo,John C. Ulrich,J. David Becherer,Frank Preugschat,Eugene L. Stewart,Daniel C. Sévin,Henning F. Kramer	14
4	2,4-Diamino-8-quinazoline carboxamides as novel, potent inhibitors of the NAD hydrolyzing enzyme CD38: Exploration of the 2-position structure-activity relationships 2018 ·Bioorganic & Medicinal Chemistry ·David N. Deaton,Curt D. Haffner,Brad R. Henke,Michael R. Jeune,Barry G. Shearer,Eugene L. Stewart,J. Darren Stuart,John C. Ulrich	12
5	Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors 2018 ·Antiviral Research ·Tomokazu Yoshinaga,Takahiro Seki,Shigeru Miki,Tadashi Miyamoto,(unknown),(unknown),Masanori Kobayashi,Akihiko Sato,Eugene L. Stewart,Mark Underwood,Tamio Fujiwara	17
6	QTL mapping of temperature sensitivity reveals candidate genes for thermal adaptation and growth morphology in the plant pathogenic fungus Zymoseptoria tritici 2016 ·Heredity ·Mark H Lendenmann,Daniel Croll,Javier Palma‐Guerrero,Eugene L. Stewart,Bruce A. McDonald	48
7	A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157 2014 ·Archives of Biochemistry and Biophysics ·Frank Preugschat,(unknown),Eric E. Boros,David Porter,Eugene L. Stewart,Lisa M. Shewchuk	18
8	Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·David G. Washburn,Tram H. Hoang,James S. Frazee,L.G. Johnson,Marlys Hammond,(unknown),Kevin P. Madauss,Shawn P. Williams,Chaya Duraiswami,Thuy Tran,Eugene L. Stewart,Eugene T. Grygielko,(unknown),Walter Trizna,Rakesh Nagilla,Jeffrey D. Bray,Scott K. Thompson	7
9	Array synthesis of progesterone receptor antagonists: 3-Aryl-1,2-diazepines 2006 ·Bioorganic & Medicinal Chemistry Letters ·Robert W. Wiethe,Eugene L. Stewart,David H. Drewry,David W. Gray,(unknown),William J. Hoekstra	14
10	The evolution of progesterone receptor ligands 2006 ·Medicinal Research Reviews ·Kevin P. Madauss,Eugene L. Stewart,Shawn P. Williams	43
11	Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·David G. Jones,Xi Liang,Eugene L. Stewart,Robert A. Noe,Lara S. Kallander,Kevin P. Madauss,Shawn P. Williams,Scott K. Thompson,David W. Gray,William J. Hoekstra	26
12	A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor 2005 ·Journal of Biological Chemistry ·Randy K. Bledsoe,Kevin P. Madauss,Jason A. Holt,C.J. Apolito,Millard H. Lambert,Kenneth H. Pearce,Thomas B. Stanley,Eugene L. Stewart,Ryan P. Trump,Timothy M. Willson,Shawn P. Williams	166
13	Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain 2004 ·Vitamins and hormones ·Randy K. Bledsoe,Eugene L. Stewart,Kenneth H. Pearce	48
14	Selection, Application, and Validation of a Set of Molecular Descriptors for Nuclear Receptor Ligands 2004 ·Combinatorial Chemistry & High Throughput Screening ·Eugene L. Stewart,Peter J. Brown,J. Bentley,Timothy M. Willson	4
15	Structural Basis for Androgen Receptor Interdomain and Coactivator Interactions Suggests a Transition in Nuclear Receptor Activation Function Dominance 2004 ·Molecular Cell ·Bin He,Robert T. Gampe,(unknown),Andrew T. Hnat,Thomas B. Stanley,Gang An,Eugene L. Stewart,(unknown),John T. Minges,Elizabeth M. Wilson	228
16	Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognitionbreakdown → 2002 ·Cell ·Randy K. Bledsoe,Valerie G. Montana,Thomas B. Stanley,Chris J. Delves,C.J. Apolito,David D. McKee,Thomas G. Consler,Derek J. Parks,Eugene L. Stewart,Timothy M. Willson,Millard H. Lambert,John T. Moore,Kenneth H. Pearce,H. Eric Xu	652
17	2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Brad R. Henke,David H. Drewry,Stacey A. Jones,Eugene L. Stewart,(unknown),Robert W. Wiethe	25
18	Ab initio and molecular mechanics (MM3) calculations on propargyl alcohol and derivatives 1996 ·Journal of Physical Organic Chemistry ·Eugene L. Stewart,(unknown),J. Phillip Bowen	9
19	Molecular Modeling Studies of Some Choline Acetyltransferase Inhibitors 1994 ·Journal of Medicinal Chemistry ·Maria Kontoyianni,Georgia B. McGaughey,Eugene L. Stewart,Chester J. Cavallito,Jonathan P. Bowen	5
20	Computer‐Assisted Molecular Modeling: Indispensable Tools for Molecular Pharmacology 1993 ·The Journal of Clinical Pharmacology ·J. Phillip Bowen,Paul S. Charifson,(unknown),Maria Kontoyianni,Aaron B. Miller,Dora M. Schnur,Eugene L. Stewart,(unknown)	8

About Eugene L. Stewart

Eugene L. Stewart is a scholar working on Virology, Physiology and Toxicology, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (17 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Genetics (1.0k citations), Endocrinology, Diabetes and Metabolism (545 citations) and Toxicology (85 citations). Eugene L. Stewart has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Thomas B. Stanley, Randy K. Bledsoe, Kenneth H. Pearce, Millard H. Lambert, Timothy M. Willson, Shawn P. Williams, C.J. Apolito, Kevin P. Madauss, John T. Moore and Thomas G. Consler. Their work appears in journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact